ASTM F offers multiple aging protocols to determine the effects of time on the sterile integrity and the physical properties of medical packaging. The ASTM F guide provides documentation for developing accelerated aging protocols to promptly determine the effects, if any at all, due to the passage of. Scope of ASTM F • Significance and Use. • Understanding Accelerated Theory & Rationale. • Tolerances and Precision. • Cautions Using Accelerated.

Author: Kajicage Zulukazahn
Country: Comoros
Language: English (Spanish)
Genre: Personal Growth
Published (Last): 1 August 2018
Pages: 184
PDF File Size: 2.72 Mb
ePub File Size: 9.43 Mb
ISBN: 191-1-65101-514-3
Downloads: 15817
Price: Free* [*Free Regsitration Required]
Uploader: Maumi

ASTM F procedure for accelerated aging is comprised of the following: Work Item s – proposed revisions of this standard.

Referenced Documents purchase separately The documents listed below are referenced within the subject standard but are not provided as part of the standard. Atsm aging test time intervals including time zero. Extracted information from ASTM F testing may be used to support t1980 date claims for medical device sterile barrier systems.

However, due to market conditions in which products become obsolete in a short time, and the need to get new products to market in the shortest possible time, real time aging studies do f19800 meet this objective. Stability testing using accelerated aging protocols shall be regarded as sufficient evidence for claimed expiry date until data from real time aging studies are available. The sterile barrier system shall maintain sterility to the point of use or until the expiry date. To ensure that accelerated aging studies do truly represent real time effects, real time aging studies must be conducted in parallel to accelerated studies.


ASTM F – 07 Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices

Define package material properties, seal strength and integrity tests, sample sizes, and acceptance criteria. ASTM-F Standard Guide for Satm Aging of Sterile Barrier Systems for Medical Devices The introduction of ast or modified products to the marketplace requires the assurance that they can be stored for an extended period one year, two years, etc.

It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. The resulting creation of an expiration date or shelf life is based on the ff1980 of a conservative estimate of the aging factor for example, Q 10 and is tentative until the results of real time aging studies are completed on the sterile barrier system.

Evaluate package, or package sstm, or both, after real time aging relative to the initial package requirements. Link to Active This link will always route to the current Active version of the standard.

Select the Q10 value Define the desired shelf life of the package marketing and product needs, etc. Evaluate the package performance after accelerated aging relative to the initial package requirements.


Refer to Practice D for standard conditions that may be used to challenge the sterile barrier system to realistic extremes in temperature and humidity conditions. Historical Version s – view previous versions of standard.


Try out our Accelerated Aging Calculator! More aggressive AAFs may be used with documented evidence to show a f180 between real time and accelerated aging.

The introduction of new or modified products to the marketplace requires the assurance that they can be stored for an extended period one year, two years, etc. Accelerated aging studies can provide an alternative means. Age samples at TAA. For more information visit www.

In parallel, age samples at real-life aging conditions TRT. The sterile barrier system material and device interaction compatibility that may be required for new product development or the resulting evaluation is not addressed in this guide. Determining AAFs are beyond the scope of this guide.

Stability testing shall demonstrate that the sterile barrier system maintains integrity over time. Real time studies must be carried out to the claimed shelf life of the product and be f180 to their completion.